Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(3)
MIXED(1)
Docetaxel
1 trial
phase_3
corbus-pharmaceuticals-inc
capcitabine
1 trial
phase_3
corbus-pharmaceuticals-inc
CRB-701
1 trial
phase_3
corbus-pharmaceuticals-inc
Cetuximab (EGFR inhibitor)
1 trial
phase_3
corbus-pharmaceuticals-inc
4 unique interventions2 categories

Analytics

Trial Phases

Phase 31

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07768189Phase 3Recruiting
A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma
Oropharyngeal Carcinoma (OPC)
PrincipalinvestigatorStart date: 2026-09-29

Research Network

Collaboration Network

5 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Oropharyngeal Carcinoma (OPC)1

Affiliations

Florida Cancer Specialists and Research Institute and Sarah Cannon Research Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

3 similar investigators found

Tomáš Novotný, MUDr.

Masaryk Memorial Cancer Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Oropharyngeal Carcinoma (OPC)
Similarity Score30%

Ari Rosenberg, MD

University of Chicago

Related
5 trials

Shared therapeutic areas:

Oropharyngeal Carcinoma (OPC)

Worked with same sponsors:

Corbus Pharmaceuticals Inc.CSPC Megalith Biopharmaceutical Co.,Ltd.
Collaborated on 1 trial
Similarity Score14%

Pablo Nenclares, MD

Barts & The London NHS Trust

Related
1 trials

Shared therapeutic areas:

Oropharyngeal Carcinoma (OPC)

Worked with same sponsors:

Corbus Pharmaceuticals Inc.CSPC Megalith Biopharmaceutical Co.,Ltd.
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07768189Phase 3PrincipalInvestigator

A Study to Evaluate CRB-701 Compared to Investigator's Choice Therapy in Previously Treated Oropharyngeal Squamous Cell Carcinoma

Oropharyngeal Carcinoma (OPC)
Recruiting

All 1 trials loaded